KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)
NCT ID: NCT02011308
Last Updated: 2017-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
217 participants
INTERVENTIONAL
2011-01-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Green Light Laser
Green light Laser
Laser vs TURP
Transurethral Resection of the Prostate (TURP)
Laser vs TURP
TURP
Transurethral Resection of the Prostate
Green light Laser
Laser vs TURP
Transurethral Resection of the Prostate (TURP)
Laser vs TURP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Green light Laser
Laser vs TURP
Transurethral Resection of the Prostate (TURP)
Laser vs TURP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Carcinoma of the prostate
* Neurogenic bladder
* Bladder carcinoma
40 Years
90 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Turku
OTHER
Tampere University
OTHER
South Ostrobothnia Health Care District
OTHER
Oulu University Hospital
OTHER
University of Helsinki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hannu Koistinen
Urologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hannu T Koistinen, M.D.
Role: PRINCIPAL_INVESTIGATOR
Helsinki University Central Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Hospital
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
34/13/03/02/08
Identifier Type: -
Identifier Source: org_study_id